Clinical Trials Browser

Unknown × Prostatic Neoplasms × Everolimus × Clear all

NCT03580239 2018-07-09

Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency

Phase 3 Unknown

Prostatic Neoplasms

NCT00657982 2009-01-21

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms